stockrow
Friday 6 November 2026
Export CERT’s income statement to Excel — free account
Certara, Inc.
CERT Healthcare Health Information Services
- Revenue
- −9.29%
- EPS
- +266.0%
- Free cash flow
- −12.1%
- Total debt
- −0.79%
Quarter to September 2026, against a year earlier
12.10
0.08
−0.66%
Follow CERT
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
3.37 | 2.14 | 2.48 | 3.52 | |
P/FCF ratio |
20.25 | 14.25 | 18.53 | 27.29 | |
P/Operating CF |
49.04 | 76.89 | 100.72 | 45.79 | |
P/B ratio |
1.33 | 0.88 | 1.05 | 1.44 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
3.62 | 2.48 | 2.74 | 3.71 | |
EV/EBITDA |
15.68 | 12.22 | 14.34 | 18.99 | |
EV/Operating CF |
15.75 | 11.49 | 13.50 | 18.23 | |
EV/FCF |
21.74 | 16.52 | 20.50 | 28.77 | |
Quick Ratio |
1.90 | 1.70 | 2.33 | 2.38 | |
Current Ratio |
2.05 | 1.88 | 2.55 | 2.58 | |
Net Debt/EBITDA |
4.72 | 9.58 | 8.16 | 0.00 | |
Debt/Assets |
18.83% | 19.49% | 20.85% | 20.58% | |
Debt/Equity |
0.28 | 0.29 | 0.30 | 0.30 | |
Asset Turnover |
0.27 | 0.27 | 0.28 | 0.27 | |
Operating CF/Net income |
(4.89) | (1.33) | (0.18) | 5.49 | |
Capex/Depreciation |
(0.37) | (0.35) | (0.57) | (0.50) | |
Interest Coverage |
0.53 | (0.87) | (0.04) | 0.46 | |
Research and Development Expense of Revenue |
10.88% | 11.49% | 10.41% | 11.35% | |
Selling, General and Administrative Expense of Revenue |
37.36% | 39.97% | 39.57% | 40.69% | |
Intangible Assets out of Total Assets |
0.71 | 0.80 | 0.76 | 0.74 | |
Share Based Compensation of Revenue |
7.90% | 6.85% | 6.53% | 6.34% | |
Graham Net Nets |
(0.13) | (0.24) | (0.12) | (0.07) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(0.11%) | (1.75%) | (6.87%) | (4.60%) | |
Free Cash Flow Yield |
4.94% | 7.02% | 5.40% | 3.66% | |
Revenue per Share |
0.65 | 0.68 | 0.60 | 0.62 | |
Operating CF per Share |
0.18 | 0.07 | 0.07 | 0.20 | |
Capex per Share |
(0.04) | (0.04) | (0.05) | (0.05) | |
Free Cash Flow per Share |
0.14 | 0.03 | 0.02 | 0.15 | |
Cash per Share |
1.18 | 0.95 | 1.19 | 1.41 | |
Shareholders Equity per Share |
6.63 | 6.45 | 6.26 | 6.40 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
6.63 | 6.45 | 6.26 | 6.40 | |
Free Cash Flow |
21.79 | 4.91 | 2.34 | 22.44 | |
Working Capital |
161.73 | 126.44 | 189.79 | 205.18 | |
Capital Expenditures |
(7.03) | (6.78) | (7.69) | (8.24) | |
Net Current Asset Value |
(178.67) | (212.76) | (121.10) | (101.66) | |
EV/EBIT |
72.17 | 114.65 | 914.75 | 2,732.59 | |
Capex to Sales |
0.07 | 0.06 | 0.08 | 0.09 | |
Price to Operating Income |
67.24 | 98.92 | 826.69 | 2,591.85 | |
| Other line items | |||||
Average Receivables |
101.88 | 94.76 | 99.13 | 92.14 | |
Average Payables |
3.27 | 4.38 | 4.10 | 3.89 | |
Average Assets |
1,565.84 | 1,530.69 | 1,471.62 | 1,475.39 | |
Average Common Equity |
1,060.73 | 1,050.66 | 1,018.55 | 1,021.36 |
Columns are period end dates · fundamentals updated 6 Nov 2026